{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:48:59Z","timestamp":1791089339695,"version":"4.1.0"},"reference-count":153,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.taap.2009.11.019","type":"journal-article","created":{"date-parts":[[2009,11,25]],"date-time":"2009-11-25T03:42:50Z","timestamp":1259120570000},"page":"154-166","source":"Crossref","is-referenced-by-count":194,"title":["Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity"],"prefix":"10.1016","volume":"243","author":[{"given":"Richard D.","family":"Beger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinchun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura K.","family":"Schnackenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2009.11.019_bib1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1517\/14740338.4.3.457","article-title":"Troponin as a marker of myocardiac damage in drug-induced cardiotoxicity","volume":"4","author":"Adamcova","year":"2005","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.taap.2009.11.019_bib2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/rtph.1998.1201","article-title":"Serum transaminase elevations as indicators of hepatic injury following the administration of drugs","volume":"27","author":"Amacher","year":"1998","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.taap.2009.11.019_bib3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1517\/14740338.6.4.341","article-title":"Acetaminophen safety and hepatotoxicity\u2014where do we go from here?","volume":"6","author":"Amar","year":"2007","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.taap.2009.11.019_bib7","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1073\/pnas.0705685105","article-title":"Evidence of different metabolic phenotypes in humans","volume":"105","author":"Assfalg","year":"2008","journal-title":"PNAS"},{"key":"10.1016\/j.taap.2009.11.019_bib10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1517\/14740338.3.2.137","article-title":"Molecular profiling approaches for identifying novel biomarkers","volume":"3","author":"Bailey","year":"2004","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.taap.2009.11.019_bib11","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1021\/tx9700679","article-title":"Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins","volume":"11","author":"Beckwith-Hall","year":"1998","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2009.11.019_bib12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11306-006-0026-2","article-title":"Metabonomic models of human pancreatic cancer using 1D proton NMR spectra of lipids in plasma","volume":"2","author":"Beger","year":"2006","journal-title":"Metabolomics"},{"key":"10.1016\/j.taap.2009.11.019_bib13","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s11306-009-0159-1","article-title":"Single valproic acid treatment inhibits glycogen and RNA ribose turnover while disrupting glucose-derived cholesterol synthesis in liver as revealed by the (U-13C6)-d-glucose tracer in mice","volume":"5","author":"Beger","year":"2009","journal-title":"Metabolomics"},{"key":"10.1016\/j.taap.2009.11.019_bib14","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1021\/pr900344m","article-title":"Individual human phenotypes in metabolic space and time","volume":"8","author":"Bernini","year":"2009","journal-title":"J. Prot. Res."},{"key":"10.1016\/j.taap.2009.11.019_bib15","doi-asserted-by":"crossref","first-page":"7110","DOI":"10.1021\/ac070928a","volume":"79","author":"Bertram","year":"2007","journal-title":"Anal. Chem."},{"key":"10.1016\/j.taap.2009.11.019_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/20014091111677","article-title":"Paracetamol (Acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues, and protective approaches","volume":"31","author":"Bessems","year":"2001","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.taap.2009.11.019_bib17","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0733-8619(05)70211-5","article-title":"The role of quantitative neurological examination in clinical neurotoxicology","volume":"18","author":"Bleecker","year":"2000","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.taap.2009.11.019_bib18","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jchromb.2008.05.008","article-title":"Quantitative profiling of bile acids in biofluids and tissues based on accurate mass high resolution LC-FT-MS: compound class targeting in a metabolomics workflow","volume":"871","author":"Bobeldijk","year":"2008","journal-title":"J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.taap.2009.11.019_bib19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/nbm.935","article-title":"NMR-based metabonomic approaches for evaluating physiological influences on biofluid composition","volume":"18","author":"Bollard","year":"2005","journal-title":"NMR Biomed."},{"key":"10.1016\/j.taap.2009.11.019_bib20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.taap.2004.06.031","article-title":"Comparative metabonomics of differential hydrazine toxicity in the rat and mouse","volume":"204","author":"Bollard","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2009.11.019_bib21","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/0192623309332992","article-title":"Discovery of metabolomics biomarkers for early detection of nephrotoxicity","volume":"37","author":"Boudonck","year":"2009","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.taap.2009.11.019_bib172","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng1201-365","article-title":"Minimum information about a microarray experiment (MIAME)-toward standards for microarray data","volume":"29","author":"Brazma","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.taap.2009.11.019_bib22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0014-5793(02)02854-5","article-title":"Earthworm species of the genus Eisenia can be phenotypically differentiated by metabolic profiling","volume":"521","author":"Bundy","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.taap.2009.11.019_bib23","doi-asserted-by":"crossref","first-page":"S138","DOI":"10.1002\/mrc.2420","article-title":"Identification and quantification of water-soluble metabolites by cryoprobe-assisted nuclear magnetic resonance spectroscopy applied to microbial fermentation","volume":"47","author":"Carrieri","year":"2009","journal-title":"Magn. Reson. Chem."},{"key":"10.1016\/j.taap.2009.11.019_bib24","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/BF02877709","article-title":"Metabonomics and diabetes mellitus","volume":"24","author":"Chen","year":"2007","journal-title":"Adv. Ther."},{"key":"10.1016\/j.taap.2009.11.019_bib25","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nature04648","article-title":"Pharmaco-metabonomic phenotyping and personalized drug treatment","volume":"440","author":"Clayton","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.taap.2009.11.019_bib26","doi-asserted-by":"crossref","first-page":"14728","DOI":"10.1073\/pnas.0904489106","article-title":"Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism","volume":"106","author":"Clayton","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2009.11.019_bib27","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1021\/tx0256127","article-title":"An integrated metabonomic investigation of acetaminophen toxicity in the mouse using NMR spectroscopy","volume":"16","author":"Coen","year":"2003","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2009.11.019_bib28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.aca.2004.02.012","article-title":"Application of nuclear magnetic resonance spectroscopy combined with principal component analysis in detecting inborn errors of metabolism using blood spots: a metabonomic approach","volume":"511","author":"Constantinou","year":"2004","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.taap.2009.11.019_bib29","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1021\/pr0503376","article-title":"Systems toxicology: integrated genomic, proteomic and metabonomic analysis of methapyrilene induced hepatotoxicity in the rat","volume":"5","author":"Craig","year":"2006","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.taap.2009.11.019_bib30","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1021\/ac0503456","article-title":"Curve-fitting method for direct quatitation of compounds in complex biological mixtures using 1H NMR: application in metabonomic toxicology studies","volume":"77","author":"Crockford","year":"2005","journal-title":"Anal. Chem."},{"key":"10.1016\/j.taap.2009.11.019_bib31","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1021\/ac051444m","article-title":"Statistical heterospectroscopy, an approach to the integrated analysis of NMR and UPLC-MS data sets: application in metabonomic toxicology studies","volume":"78","author":"Crockford","year":"2006","journal-title":"Anal. Chem."},{"key":"10.1016\/j.taap.2009.11.019_bib32","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.nut.2005.02.009","article-title":"Suppressive effect of corn bran hemicellulose on liver injury induced by d-galactosamine in rats","volume":"21","author":"Daizo","year":"2005","journal-title":"Nutrition"},{"key":"10.1016\/j.taap.2009.11.019_bib173","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1021\/ac051632c","article-title":"Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics","volume":"78","author":"Dieterle","year":"2006","journal-title":"Anal. Chem."},{"key":"10.1016\/j.taap.2009.11.019_bib33","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1093\/clinchem\/32.9.1702","article-title":"Chemometrics: an overview","volume":"32","author":"Deming","year":"1986","journal-title":"Clin. Chem."},{"key":"10.1016\/j.taap.2009.11.019_bib34","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/clinchem\/25.7.1263","article-title":"Decreased aminotransferase activity of serum and various tissues in the rat after cefazolin treatment","volume":"25","author":"Dhami","year":"1979","journal-title":"Clin. Chem."},{"key":"10.1016\/j.taap.2009.11.019_bib35","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1093\/clinchem\/46.12.2050","article-title":"Diagnosis and monitoring of hepatic injury: II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring","volume":"46","author":"Dufour","year":"2000","journal-title":"Clin. Chem."},{"key":"10.1016\/j.taap.2009.11.019_bib36","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1021\/ac0517085","article-title":"Assessment of analytical reproducibility of 1H NMR spectroscopy based metabonomics for large-scale epidemiological research: the INTERMAP study","volume":"78","author":"Dumas","year":"2006","journal-title":"Anal. Chem."},{"key":"10.1016\/j.taap.2009.11.019_bib37","doi-asserted-by":"crossref","first-page":"12511","DOI":"10.1073\/pnas.0601056103","article-title":"Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice","volume":"103","author":"Dumas","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2009.11.019_bib38","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.trac.2004.11.021","article-title":"Metabolomics: current analytical platforms and methodologies","volume":"24","author":"Dunn","year":"2005","journal-title":"Trends Anal. Chem."},{"key":"10.1016\/j.taap.2009.11.019_bib39","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0003-2670(03)00121-1","article-title":"Toxicity classification from metabonomic data using a density superposition approach: \u2018CLOUDS\u2019","volume":"490","author":"Ebbels","year":"2003","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.taap.2009.11.019_bib40","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1021\/pr0703021","article-title":"Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach","volume":"6","author":"Ebbels","year":"2007","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.taap.2009.11.019_bib42","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/toxsci\/kfm184","article-title":"The utility of a rodent model in detecting pediatric drug-induced nephrotoxicity","volume":"99","author":"Espandiari","year":"2007","journal-title":"Tox. Sci."},{"key":"10.1016\/j.taap.2009.11.019_bib43","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/jat.1314","article-title":"Age-related differences in susceptibility to toxic effects of valproic acid in rats","volume":"28","author":"Espandiari","year":"2008","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.taap.2009.11.019_bib44","first-page":"4","article-title":"Genetic networks of liver metabolism revealed by integration of metabolomic and transcriptional profiling","volume":"e1000034","author":"Ferrara","year":"2008","journal-title":"PLoS Genet"},{"key":"10.1016\/j.taap.2009.11.019_bib45","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1023\/A:1013713905833","article-title":"Metabolomics\u2013The link between genotypes and phenotypes","volume":"48","author":"Fiehn","year":"2002","journal-title":"Plant Mol. Biol."},{"key":"10.1016\/j.taap.2009.11.019_bib49","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1021\/tx0498915","article-title":"Integrated metabonomic analysis of the multiorgan effects of hydrazine toxicity in the rat","volume":"18","author":"Garrod","year":"2005","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2009.11.019_bib51","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0014-5793(00)02147-5","article-title":"An NMR-based metabonomic approach to investigate the biochemical consequences of genetic strain differences: application to the C57BL10J and Alpk:ApfCD mouse","volume":"484","author":"Gavaghan","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.taap.2009.11.019_bib52","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1053\/j.ajkd.2006.08.009","article-title":"Aminoglycoside-associated Fanconi syndrome. Am. J","volume":"48","author":"Ghiculescu","year":"2006","journal-title":"Kidney Dis."},{"key":"10.1016\/j.taap.2009.11.019_bib53","first-page":"e1000282","article-title":"Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum","volume":"4","author":"Gieger","year":"2008","journal-title":"Genetic"},{"key":"10.1016\/j.taap.2009.11.019_bib54","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1021\/pr070183p","article-title":"Within-day reproducibility of an HPLC-MS-based method for metabonomic analysis: application to human urine","volume":"6","author":"Gika","year":"2007","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.taap.2009.11.019_bib55","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11306-007-0081-3","article-title":"Proposed minimum reporting standards for data analysis in metabolomics","volume":"3","author":"Goodacre","year":"2007","journal-title":"Metabolomics"},{"key":"10.1016\/j.taap.2009.11.019_bib56","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.cbpa.2003.08.008","article-title":"Metabonomics: NMR spectroscopy and pattern recognition analysis of body fluids and tissues for characterisation of xenobiotic toxicity and disease diagnosis","volume":"7","author":"Griffin","year":"2003","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.taap.2009.11.019_bib57","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0304-4165(02)00475-0","article-title":"Cellular environment of metabolites and a metabonomic study of tamoxifen in endometrial cells using gradient high resolution magic angle spinning 1H NMR spectroscopy","volume":"1619","author":"Griffin","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.taap.2009.11.019_bib58","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11306-007-0077-z","article-title":"Standard reporting requirements for biological samples in metabolomics experiments: mammalian\/in vivo experiments","volume":"3","author":"Griffin","year":"2007","journal-title":"Metabolomics"},{"key":"10.1016\/j.taap.2009.11.019_bib60","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1271\/bbb.61.1358","article-title":"Long-term effects of water-soluble corn bran hemicellulose on glucose tolderance in obese and non-obese patients, improved insulin sensitivity and glucose metabolism in obese subjects","volume":"61","author":"Hanai","year":"1997","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.taap.2009.11.019_bib61","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11306-007-0071-5","article-title":"A roadmap for the establishment of standard data exchange structures for metabolomics","volume":"3","author":"Hardy","year":"2007","journal-title":"Metabolomics"},{"key":"10.1016\/j.taap.2009.11.019_bib62","first-page":"188","article-title":"High-throughput screening, metabolomics and drug discovery","volume":"9","author":"Harrigan","year":"2006","journal-title":"IDrugs"},{"key":"10.1016\/j.taap.2009.11.019_bib63","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.2165\/00003088-200342130-00001","article-title":"Dietary effects on drug metabolism and transport","volume":"42","author":"Harris","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.taap.2009.11.019_bib64","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nm0506-510","article-title":"Personalized medicine progresses","volume":"12","author":"Haselden","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.taap.2009.11.019_bib65","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/01926230590958146","article-title":"Profiles of metabolites and gene expression in rats with chemically induced hepatic necrosis","volume":"33","author":"Heijne","year":"2005","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.taap.2009.11.019_bib66","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0026-895X(25)09200-4","article-title":"Nuclear magnetic resonance spectroscopy and pattern recognition analysis of the biochemical processes associated with the progression of and recovery from nephrotoxic lesions in the rat induced by mercury(II) chloride and 2-bromoethanamine","volume":"42","author":"Holmes","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.taap.2009.11.019_bib67","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.nurx.2006.05.004","article-title":"The application of NMR-based metabonomics in neurological disorders","volume":"3","author":"Holmes","year":"2006","journal-title":"NeuroRx"},{"key":"10.1016\/j.taap.2009.11.019_bib68","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cell.2008.08.026","article-title":"Metabolomic phenotyping in health and disease","volume":"134","author":"Holmes","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.taap.2009.11.019_bib70","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1742-7843.2006.pto_455.x","article-title":"A metabonomics study of the hepatotoxicants galactosamine, methylene dianiline and clofibrate in rats","volume":"99","author":"Ishihara","year":"2006","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.taap.2009.11.019_bib71","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2165\/00002018-200124070-00001","article-title":"Drug-induced liver disorders: implications for drug development and regulation","volume":"24","author":"Kaplowitz","year":"2001","journal-title":"Drug Safety"},{"key":"10.1016\/j.taap.2009.11.019_bib72","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd1750","article-title":"Idiosyncratic drug hepatotoxicity","volume":"4","author":"Kaplowitz","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.taap.2009.11.019_bib73","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2217\/14622416.8.4.369","article-title":"Nutrigenomics: concepts and applications to pharmacogenomics and clinical medicine","volume":"8","author":"Kaput","year":"2007","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.taap.2009.11.019_bib74","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1021\/tx0255774","article-title":"Analytical reproducibility in 1H NMR-based metabonomic urinalysis","volume":"15","author":"Keun","year":"2002","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2009.11.019_bib75","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1021\/tx034212w","article-title":"Geometric trajectory analysis of metabolic responses to toxicity can define treatment specific profiles","volume":"17","author":"Keun","year":"2004","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2009.11.019_bib76","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pharmthera.2005.06.008","article-title":"Metabonomic modeling of drug toxicity","volume":"109","author":"Keun","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.taap.2009.11.019_bib77","doi-asserted-by":"crossref","first-page":"551","DOI":"10.33549\/physiolres.930869","article-title":"Protective effect of S-adenosylmethionine against galactosamine-induced injury of rat hepatocytes in primary culture","volume":"55","author":"Kucera","year":"2006","journal-title":"Physiol. Res."},{"key":"10.1016\/j.taap.2009.11.019_bib78","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1021\/ac800728t","article-title":"Chemometrics","volume":"80","author":"Lavine","year":"2008","journal-title":"Anal. Chem."},{"key":"10.1016\/j.taap.2009.11.019_bib79","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","article-title":"Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies","volume":"279","author":"Lazarou","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.taap.2009.11.019_bib80","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/hep.20293","article-title":"Acetaminophen and the U.S. Acute Liver Failure Study Group: lowering the risks of hepatic failure.","volume":"40","author":"Lee","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2009.11.019_bib82","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1080\/135475000750052439","article-title":"A 1H NMR spectroscopic study of the biochemical effects of ifosfamide in the rat: evaluation of potential biomarkers","volume":"5","author":"Lenz","year":"2000","journal-title":"Biomarkers"},{"key":"10.1016\/j.taap.2009.11.019_bib83","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jpba.2004.02.013","article-title":"Cyclosporin A-induced changes in endogenous metabolites in rat urine: a metabonomic investigation using high field 1H NMR spectroscopy, HPLC-TOF\/MS and chemometrics","volume":"35","author":"Lenz","year":"2004","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.taap.2009.11.019_bib84","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1039\/b400159c","article-title":"A metabonomic investigation of the biochemical effects of mercuric chloride in the rat using 1H NMR and HPLC-TOF\/MS: time dependent changes in the urinary profile of endogenous metabolites as a result of nephrotoxicity","volume":"129","author":"Lenz","year":"2004","journal-title":"Analyst"},{"key":"10.1016\/j.taap.2009.11.019_bib85","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/13547500500094034","article-title":"Metabonomics with 1H-NMR spectroscopy and liquid chromatography-mass spectrometry applied to the investigation of metabolic changes caused by gentamicin-induced nephrotoxicity in the rat","volume":"10","author":"Lenz","year":"2005","journal-title":"Biomarkers"},{"key":"10.1016\/j.taap.2009.11.019_bib86","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1021\/pr0605217","article-title":"Analytical strategies in metabonomics","volume":"6","author":"Lenz","year":"2007","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.taap.2009.11.019_bib87","first-page":"128","article-title":"Hepatic toxicity of nonsteroidal anti-inflammatory drugs","volume":"3","author":"Lewis","year":"1984","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.taap.2009.11.019_bib89","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0041-008X(02)00079-0","article-title":"Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project","volume":"187","author":"Lindon","year":"2003","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2009.11.019_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13547500410001668379","article-title":"Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis","volume":"9","author":"Lindon","year":"2004","journal-title":"Biomarkers"},{"key":"10.1016\/j.taap.2009.11.019_bib91","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2217\/14622416.6.7.691","article-title":"The consortium for metabonomic toxicology (COMET): aims, activities and achievements","volume":"6","author":"Lindon","year":"2005","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.taap.2009.11.019_bib92","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/nbt0705-833","article-title":"Summary recommendations for standardization and reporting of metabolic analyses","volume":"23","author":"Lindon","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.taap.2009.11.019_bib93","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1600-079X.2006.00321.x","article-title":"Urinary metabolites and antioxidant products of exogenous melatonin in the mouse","volume":"40","author":"Ma","year":"2006","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.taap.2009.11.019_bib94","first-page":"101","article-title":"Aminoaciduria is an earlier index of renal tubular damage than conventional renal disease markers in the gentamicin-rat model of acute renal failure","volume":"14","author":"Macpherson","year":"1991","journal-title":"Clin. Invest. Med."},{"key":"10.1016\/j.taap.2009.11.019_bib95","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1258\/000456303321016132","article-title":"Proton nuclear magnetic resonance spectroscopy of body fluids in the field of inborn errors of metabolism","volume":"40","author":"Moolenaar","year":"2003","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.taap.2009.11.019_bib96","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1001\/archinte.167.16.1752","article-title":"Serious adverse drug events reported to the Food and Drug Administration, 1998\u20132005","volume":"167","author":"Moore","year":"2007","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.taap.2009.11.019_bib97","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11306-007-0067-1","article-title":"Standard reporting requirements for biological samples in metabolomics experiments: environmental context","volume":"3","author":"Morrison","year":"2007","journal-title":"Metabolomics"},{"key":"10.1016\/j.taap.2009.11.019_bib98","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1021\/tx034123j","article-title":"Use of metabonomics to identify impaired fatty acid metabolism as the mechanism of a drug-induced toxicity","volume":"17","author":"Mortishire-Smith","year":"2004","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2009.11.019_bib100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2174\/138920006774832569","article-title":"Altered CYP expression and function in response to dietary factors: potential roles in disease pathogenesis","volume":"7","author":"Murray","year":"2006","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.taap.2009.11.019_bib101","first-page":"480","article-title":"Cytochrome P450: decision-making tools for personalized therapeutics","volume":"8","author":"Murray","year":"2006","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.taap.2009.11.019_bib102","doi-asserted-by":"crossref","first-page":"F910","DOI":"10.1152\/ajprenal.2000.279.5.F910","article-title":"Melatonin attenuates acute renal failure and oxidative stress induced by mercuric chloride in rats","volume":"279","author":"Nava","year":"2000","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.taap.2009.11.019_bib103","first-page":"165","article-title":"Interactions of food and dietary supplements with drug metabolising cytochrome P450 enzymes","volume":"56","author":"Nekvindova","year":"2007","journal-title":"Ceska Slov. Farm."},{"key":"10.1016\/j.taap.2009.11.019_bib104","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/004982599238047","article-title":"\u2018Metabonomics\u2019: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data","volume":"29","author":"Nicholson","year":"1999","journal-title":"Xenobiotica"},{"key":"10.1016\/j.taap.2009.11.019_bib105","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrd728","article-title":"Metabonomics: a platform for studying drug toxicity and gene function","volume":"1","author":"Nicholson","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.taap.2009.11.019_bib106","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/nrmicro1152","article-title":"Gut microbes, mammalian metabolism and personalized healthcare","volume":"3","author":"Nicholson","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.taap.2009.11.019_bib107","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1021\/pr070795+","article-title":"COMET and the challenge of drug safety screening","volume":"6","author":"Nicholson","year":"2007","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.taap.2009.11.019_bib108","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1517\/17425255.3.4.527","article-title":"Biochemical mechanisms of nephrotoxicity: application for metabolomics","volume":"3","author":"Niemann","year":"2007","journal-title":"Exp. Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.taap.2009.11.019_bib109","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1080\/13547500500399979","article-title":"Increased serum bile acids as a possible biomarker of hepatotoxicity in Brazilian workers exposed to solvents in car repainting shops","volume":"10","author":"Nunes De Paiva","year":"2005","journal-title":"Biomarkers"},{"key":"10.1016\/j.taap.2009.11.019_bib110","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1021\/jf00039a010","article-title":"Antioxidative activity of corn bran hemicellulose fragments","volume":"42","author":"Ohta","year":"1994","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.taap.2009.11.019_bib111","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00216-006-0546-7","article-title":"Principal component analysis of urine metabolites detected by NMR and DESI-MS in patients with inborn errors of metabolism","volume":"387","author":"Pan","year":"2006","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.taap.2009.11.019_bib112","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","article-title":"Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients","volume":"329","author":"Pirmohamed","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.taap.2009.11.019_bib113","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1039\/b501767j","article-title":"A rapid screening approach to metabonomics using UPLC and oa-TOF mass spectrometry: application to age, gender and diurnal variation in normal\/Zucker obese rats and black, white and nude mice","volume":"130","author":"Plumb","year":"2005","journal-title":"Analyst"},{"key":"10.1016\/j.taap.2009.11.019_bib114","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1002\/rcm.2550","article-title":"UPLC\/MS(E); a new approach for generating molecular fragment information for biomarker structure elucidation","volume":"20","author":"Plumb","year":"2006","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.taap.2009.11.019_bib115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/chromsci\/46.3.193","article-title":"A rapid simple approach to screening pharmaceutical products using ultra-performance LC couple to time-of-flight mass spectrometry and pattern recognition","volume":"46","author":"Plumb","year":"2008","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.taap.2009.11.019_bib116","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1021\/pr801078a","article-title":"Application of ultra performance liquid chromatography-mass spectrometry to profiling rat and dog bile","volume":"8","author":"Plumb","year":"2009","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.taap.2009.11.019_bib117","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1038\/sj.ki.5000433","article-title":"Metabolomic study of cisplatin-induced nephrotoxicity","volume":"69","author":"Portilla","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.taap.2009.11.019_bib118","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/83496","article-title":"A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations","volume":"19","author":"Raamsdonk","year":"2001","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.taap.2009.11.019_bib119","doi-asserted-by":"crossref","first-page":"12360","DOI":"10.1021\/ja063773h","article-title":"DFTMP, an NMR Reagent for assessing the near-neutral pH of biological samples","volume":"126","author":"Reily","year":"2006","journal-title":"JACS"},{"key":"10.1016\/j.taap.2009.11.019_bib120","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1081\/DCT-120014789","article-title":"NMR-based metabolomics","volume":"25","author":"Reo","year":"2002","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.taap.2009.11.019_bib121","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/toxsci\/57.2.326","article-title":"Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants","volume":"57","author":"Robertson","year":"2000","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2009.11.019_bib122","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1385\/CT:1:1:07","article-title":"Metabonomic assessment of vasculitis in rats","volume":"1","author":"Robertson","year":"2001","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.taap.2009.11.019_bib123","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/toxsci\/kfi102","article-title":"Metabonomics in toxicology: a review","volume":"85","author":"Robertson","year":"2005","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2009.11.019_bib125","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11306-006-0040-4","article-title":"Proposed reporting requirements for the description of NMR-based metabolomics experiments","volume":"3","author":"Rubtsov","year":"2007","journal-title":"Metabolomics"},{"key":"10.1016\/j.taap.2009.11.019_bib124","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11306-007-0069-z","article-title":"Metabolomics standards initiative: ontology working group work in progress","volume":"3","author":"Sansone","year":"2007","journal-title":"Metabolomics"},{"key":"10.1016\/j.taap.2009.11.019_bib126","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11306-005-1110-8","article-title":"NMR-based metabonomic evaluation of livers from rats chronically treated with tamoxifen, mestranol, and phenobarbital","volume":"1","author":"Schnackenberg","year":"2005","journal-title":"Metabonomics"},{"key":"10.1016\/j.taap.2009.11.019_bib127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/omi.2006.10.1","article-title":"An integrated study of acute effects of valproic acid in the liver using metabonomics, proteomics, and transcriptomics platforms","volume":"10","author":"Schnackenberg","year":"2006","journal-title":"OMICS"},{"key":"10.1016\/j.taap.2009.11.019_bib128","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11306-006-0046-y","article-title":"Evaluation of NMR spectral data of urine in conjunction with measured clinical chemistry and histopathology parameters to assess the effects of liver and kidney toxicants","volume":"2","author":"Schnackenberg","year":"2007","journal-title":"Metabolomics"},{"issue":"Suppl. 7","key":"10.1016\/j.taap.2009.11.019_bib129","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1471-2105-8-S7-S3","article-title":"Metabonomics evaluations of age-related changes in the urinary compositions of male Sprague\u2013Dawley rats and effects of data normalization methods on statistical and quantitative analysis","author":"Schnackenberg","year":"2007","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.taap.2009.11.019_bib130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.taap.2008.11.015","article-title":"Evaluations of the trans-sulfuration pathway in multiple liver toxicity studies","volume":"235","author":"Schnackenberg","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2009.11.019_bib131","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1034\/j.1600-079X.2002.01858.x","article-title":"Melatonin protects against gentamicin-induced nephrotoxicity in rats","volume":"32","author":"Sener","year":"2002","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.taap.2009.11.019_bib132","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/01.ftd.0000179846.30342.65","article-title":"Biomarkers for toxicodynamic monitoring of immunosuppressants: NMR-based quantitative metabonomics of the blood","volume":"27","author":"Serkova","year":"2005","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.taap.2009.11.019_bib133","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1001\/archinte.151.2.260","article-title":"Alanine aminotransferase in clinical practice. A review","volume":"151","author":"Sherman","year":"1991","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.taap.2009.11.019_bib134","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.toxlet.2007.07.010","article-title":"NMR-spectroscopy-based metabonomic approach to the analysis of Bay41-4109, a novel anti-HBV compound, induced hepatotoxicity in rats","volume":"173","author":"Shi","year":"2007","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.taap.2009.11.019_bib135","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1006\/taap.2002.9465","article-title":"Effect of dexamethasone on the metabonomics profile associated with phosphodiesterase inhibitor-induced vascular lesions in rats","volume":"183","author":"Slim","year":"2002","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2009.11.019_bib137","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11306-007-0082-2","article-title":"Proposed minimum reporting standards for chemical analysis","volume":"3","author":"Sumner","year":"2007","journal-title":"Metabolomics"},{"key":"10.1016\/j.taap.2009.11.019_bib138","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jchromb.2008.04.008","article-title":"Metabonomics evaluation of urine from rats given acute and chronic doses of acetaminophen using NMR and UPLC\/MS","volume":"871","author":"Sun","year":"2008","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.taap.2009.11.019_bib139","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2174\/187231209789352139","article-title":"Pharmacokinetic studies of acetaminophen and metabolites and their correlations with toxicity using metabonomics","volume":"3","author":"Sun","year":"2009","journal-title":"Drug Metab. Lett."},{"key":"10.1016\/j.taap.2009.11.019_bib140","unstructured":"Sun, J., Schnackenberg, L.K., Hansen, D.K., Beger, R.D., in press. A study of valproic acid-induced endogenous and exogenous metabolite alterations using LC\/MS-based metabolomics. Bioanalysis."},{"key":"10.1016\/j.taap.2009.11.019_bib141","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1074-5521(04)00031-6","article-title":"Toxicogenomics in predictive toxicology in drug development","volume":"11","author":"Suter","year":"2004","journal-title":"Chem. Biol."},{"key":"10.1016\/j.taap.2009.11.019_bib142","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1471-2105-8-93","article-title":"Normalization method for metabolomics data using optimal selection of multiple internal standards","volume":"8","author":"Sysi-Aho","year":"2007","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.taap.2009.11.019_bib143","first-page":"1","article-title":"Comparison of screening approaches","volume":"13","author":"Tilson","year":"1992","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.taap.2009.11.019_bib144","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1517\/17425255.2.5.697","article-title":"Mechanistic biomarkers for cytotoxic acute kidney injury","volume":"2","author":"Vaidya","year":"2006","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.taap.2009.11.019_bib145","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/ajcn\/79.2.185","article-title":"Renal metabolism of amino acids: its role in interorgan amino acid exchange","volume":"79","author":"van de Poll","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.taap.2009.11.019_bib146","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11306-007-0080-4","article-title":"Standard reporting requirements for biological samples in metabolomics experiments: microbial and in vitro biology experiments","volume":"3","author":"van der Werf","year":"2007","journal-title":"Metabolomics"},{"key":"10.1016\/j.taap.2009.11.019_bib147","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1021\/ac051705s","article-title":"Metabonomics and biomarker discovery: LC-MS metabolic profiling and constant neutral loss scanning combined with multivariate data analysis for mercapturic acid analysis","volume":"78","author":"Wagner","year":"2006","journal-title":"Anal. Chem."},{"key":"10.1016\/j.taap.2009.11.019_bib148","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1021\/ac062153w","article-title":"Tools in metabonomics: an integrated validation approach for LC-MS metabolic profiling of mercapturic acids in human urine","volume":"79","author":"Wagner","year":"2007","journal-title":"Anal. Chem."},{"key":"10.1016\/j.taap.2009.11.019_bib149","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/10408440590935620","article-title":"Role of metabolism in drug-induced idiosyncratic hepatotoxicity","volume":"35","author":"Walgren","year":"2005","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.taap.2009.11.019_bib150","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00003088-199631010-00004","article-title":"Influence of diet and nutritional status on drug metabolism","volume":"31","author":"Walter-Sack","year":"1996","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.taap.2009.11.019_bib151","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF00497793","article-title":"The toxicological significance of decreased activities of blood alanine and aspartate aminotransferase","volume":"15","author":"Waner","year":"1991","journal-title":"Vet. Res. Commun."},{"key":"10.1016\/j.taap.2009.11.019_bib152","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jchromb.2009.01.007","article-title":"Normalization strategies for metabonomic analysis of urine samples","volume":"877","author":"Warrack","year":"2009","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.taap.2009.11.019_bib155","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1021\/tx030019q","article-title":"1H NMR pattern recognition and 31P NMR studies with d-serine in rat urine and kidney, time- and dose-related metabolic effects","volume":"16","author":"Williams","year":"2003","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2009.11.019_bib156","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jpba.2005.01.013","article-title":"A combined 1H NMR and HPLC-MC-based metabonomic study of urine from obese (fa\/fa) Zucker and normal Wistar-derived rats","volume":"38","author":"Williams","year":"2005","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.taap.2009.11.019_bib157","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1039\/b500852b","article-title":"The metabonomics of aging and development in the rat: an investigation into the effect of age on the profile of endogenous metabolites in the urine of male rats using 1H NMR and HPLC-TOF MS","volume":"1","author":"Williams","year":"2005","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.taap.2009.11.019_bib159","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1021\/pr049769r","article-title":"High resolution \u201cultra performance\u201d liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies","volume":"4","author":"Wilson","year":"2005","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.taap.2009.11.019_bib160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-7439(98)00075-6","article-title":"Chemometrics, present and future success","volume":"44","author":"Wold","year":"1998","journal-title":"Chemometr. Intell. Lab. Syst."},{"key":"10.1016\/j.taap.2009.11.019_bib161","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S1872-2040(08)60005-5","article-title":"Gas chromatography-mass spectrometry based on metabonomics study of carbon tetrachloride-induced acute liver injury in mice","volume":"35","author":"Xin","year":"2007","journal-title":"Chinese, J. Anal. Chem."},{"key":"10.1016\/j.taap.2009.11.019_bib162","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.bcp.2008.05.016","article-title":"Role of mitochondrial dysfunction in cellular responses to S-(1,2-dichlorovinyl)-l-cysteine in primary cultures of human proximal tubular cells","volume":"76","author":"Xu","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2009.11.019_bib163","first-page":"29","article-title":"\u201cIn vivo\u201d inhibition of murine liver aspartate aminotransferase by isoniazid","volume":"6","author":"Yamada","year":"1984","journal-title":"Acta Vitaminol. Enzymol."},{"key":"10.1016\/j.taap.2009.11.019_bib164","first-page":"289","article-title":"Inhibition of serum aspartate aminotransferase induced by isoniazid administration in mice","volume":"6","author":"Yamada","year":"1984","journal-title":"Acta Vitaminol. Enzymol."},{"key":"10.1016\/j.taap.2009.11.019_bib165","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.chroma.2004.10.100","article-title":"Strategy for metabonomics research based on high-performance liquid chromatography and liquid chromatography coupled with tandem mass spectrometry","volume":"1084","author":"Yang","year":"2005","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.taap.2009.11.019_bib166","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1021\/tx800225q","article-title":"Bile acids metabonomic study on the CCL4- and alpha-naphthylisothiocyanate-induced animal models: quantitative analysis of 22 bile acids by ultraperformance liquid chromatography-mass spectrometry","volume":"21","author":"Yang","year":"2008","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2009.11.019_bib168","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ymben.2004.09.003","article-title":"Evolution of intrahepatic carbon, nitrogen, and energy metabolism in a d-galactosamine-induced rat liver failure model","volume":"7","author":"Yokoyama","year":"2005","journal-title":"Metab. Eng."},{"key":"10.1016\/j.taap.2009.11.019_bib169","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1096\/fasebj.5.7.2010061","article-title":"Choline, an essential nutrient for humans","volume":"5","author":"Zeisel","year":"1991","journal-title":"FASEB J."},{"key":"10.1016\/j.taap.2009.11.019_bib170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/01926230600588562","article-title":"Mechanisms and biomarkers of cardiovascular injury induced by phosphodiesterase inhibitor III SK&F 95654 in the spontaneously hypertensive rat","volume":"34","author":"Zhang","year":"2006","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.taap.2009.11.019_bib171","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/toxsci\/kfm260","article-title":"Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chrominum","volume":"101","author":"Zhou","year":"2008","journal-title":"Toxicol. Sci."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X09004852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X09004852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T07:01:45Z","timestamp":1739430105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X09004852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":153,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0041008X09004852"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2009.11.019","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}